Technically Speaking: Is Everything “Priced In?”
Futures Power Higher On Upbeat Chinese, German Data
US open – Stocks gaining ahead of the Fed
AstraZeneca’s Pivotal Covid-19 Vaccine Trial Kept On Hold In US- Report
3 ways pharma marketers can draw inspiration from digitally-native brands
UK extends COVID-19 vaccine supply deal with Valneva
Asian stocks edge up after Wall Street
Novus Therapeutics Explodes 166% On Anelixis Deal, Capital Raise
Hologic Prices $950M Debt Offer; As C-19 Testing Set To Drive Massive F4Q20 Beat
Marinus Spikes 63% On Positive Phase 3 Trial For Rare Genetic Epilepsy
A Man's Gotta Know His Own Limitations
US Close – All about M&A today, Stopgap likely, OPEC+ to stay the course, Gold shines, Biden Momentum
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Moderna or BioNTech: J.P. Morgan Lays Odds On the Race to a COVID-19 Vaccine
Monday’s Market Snapshot: Here’s What You Need To Know Right Now
Dynavax Scores Supply Deal For Valneva’s Covid-19 Vaccine; Street Bullish
Charlotte's Web Down 6% As Pandemic Fallout Causes Earnings Miss
Merck To Buy $1B Seattle Genetics Stake For Oncology Collab
NYC Cancels Macy's Thanksgiving Day Parade; Russia Recruits 55k Volunteers For COVID-19 Vaccine Trials: Live Updates
These 3 Penny Stocks Could Double (Or More), Says BTIG
Euro Firm on Positive Market Sentiment & Good Data, Can Face Troubles in Future
Futures Surge On Monday Merger Mania, Fresh Vaccine Hopes
AUD/USD calm ahead of RBA minutes
Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will
Monday’s Pre-Market: Here’s What You Need To Know Before The Market Opens
UK Presses Ahead, China Strikes Out at German Pork Producers, and Moody's Weighs on Turkey
AZ resumes UK coronavirus vaccine trial
Galapagos Pops 9% On Positive Result Of Novesa Trial
Molecular Completes Manufacturing For Covid-19 Drug, Plans Nov. Human Trial
Japanese Yen Soft amid Risk Appetite, Manages to Hold Ground Against Some Rivals